author-photo

Vanessa Samouëlian

Université de Montréal

54

Papers

366

Citations

Citation Trend

Filter By

Papers (36) Sort By

Journal Conference Others

Vulvar Cutaneous Myxoma in a Patient With Carney Complex: Avoiding Pitfalls of Myxoid Lesions of the Vulva.

2021 International Journal of Surgical Pathology
Show All
- Source
- Cite
- Save
Citations (0)
EPV063/#357 The impact of surgical approach in cases with no residual disease on hysterectomy specimen: a 4C (Canadian cervical cancer collaborative) working group study

2021
Show All
- Source
- Cite
- Save
Citations (0)
O003/#149 Antitumor activity of dostarlimab in patients with advanced or recurrent mismatch repair–deficient or proficient–cancer by prior therapy: results from the garnet study

2021
Show All
- Source
- Cite
- Save
Citations (0)
76P Analysis of antitumor activity of dostarlimab by tumor mutational burden (TMB) in patients (pts) with endometrial cancer (EC) in the GARNET trial

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (1)
Clinical activity and safety of the anti-PD-1 monoclonal antibody dostarlimab for patients with recurrent or advanced dMMR endometrial cancer.

2021 Future Oncology
Show All
- Source
- Cite
- Save
Citations (0)
OP005/#352 Safety of vaginal hysterectomy for cervical cancer: a multicenter cohort study on behalf of the 4C (Canadian cervical cancer collaborative) working group

2021
Show All
- Source
- Cite
- Save
Citations (0)
Surgical Management of Intravascular leiomyomatosis

2021 Journal of Vascular Surgery Cases and Innovative Techniques
Show All
- Source
- Cite
- Save
Citations (0)
GOG 3016/ENGOT-cx9: An open-label, multi-national, randomized, phase III trial of cemiplimab, an anti-programmed death (PD)-1, versus investigator's choice (IC) chemotherapy in >= 2 line recurrent or metastatic cervical cancer

2020 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Safety and efficacy of the anti–PD-1 monoclonal antibody dostarlimab in patients with recurrent or advanced dMMR endometrial cancer

2020 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (2)